Salirasib

salirasib · Concordia Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Salirasib, covering 2011-06-09 to 2011-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Salirasib to Treat Non-Small Cell Lung Cancer [Phase 2]